Comments*

 
  • Chemistry & Chemical Engineering

  • Events 

    Monday, September 15, 2014 | 12:00 PM - 4:00 PM

    Click Chemistry in Biology and Medicine: New Developments and Strategies

    Keynote Speakers: Jim Paulson (The Scripps Research Institute), K. Barry Sharpless (The Scripps Research Institute)
    Speakers: Yimon Aye (Cornell University), David A. Spiegel (Yale University), Peng Wu (Albert Einstein College of Medicine)

    Click chemistry offers a reliable method for discovering chemical connectivity, with great potential in drug discovery and biomedical research. This symposium explores recent developments that offer new technologies for disease diagnosis and therapy.

  • Past Events

    Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM

    Chemical Biology Discussion Group Year-End Symposium

    Keynote Speaker: Michael Marletta (The Scripps Research Institute)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.

    Thursday, March 20, 2014 | 6:00 PM - 8:30 PM

    Systems Biology Approaches to Secondary Metabolites and Metabonomics

    Speaker: Sean F. Brady (The Rockefeller University), Steven Edgar (MIT), Justin Nodwell (University of Toronto), Kang Zhou (MIT)

    Secondary metabolites or idiolites play many roles in biological systems, including communication, defense and signaling. This symposium takes a systems biology approach to explore their biological effects and potential benefits for human health.

    Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM

    Antibody-Drug Conjugates: An Emerging Modality for the Treatment of Cancer

    Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)

    Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.

    Wednesday, December 11, 2013 | 12:00 PM - 4:00 PM

    Bioorthogonal Chemistry in Biology and Medicine

    Speakers: T. Eric Ballard (Pfizer Worldwide Research and Development), Joseph M. Fox (University of Delaware), Howard C. Hang (The Rockefeller University), Minkui Luo (Memorial Sloan-Kettering Cancer Center), Lisa Shah (SUNY Stony Brook)

    Innovations in chemistry often lead to breakthroughs in biology and medicine. This symposium highlights advances in bioorthogonal chemistry, affording opportunities to explore biology and facilitating the synthesis of diagnostics and therapeutics.

  • Publications 

    eBriefing

    Systems Biology Approaches to Secondary Metabolites and Metabonomics

    Organizers: Manuel X. Duval (Boehringer Ingelheim Pharmaceuticals; University of New Haven), Thomas B. Freeman (Boehringer Ingelheim Pharmaceuticals), and Jennifer Henry (The New York Academy of Sciences)
    Speakers: Sean F. Brady (The Rockefeller University), Steven Edgar (Massachusetts Institute of Technology), Justin Nodwell (University of Toronto, Canada), and Kang Zhou (Massachusetts Institute of Technology)

    This eBriefing explores a systems biology approach to secondary metabolites and their networks, looking at their biological effects and potential benefits for human health.

    eBriefing

    Nanomedicines: Addressing the Scientific and Regulatory Gap

    Organizers: Raj Bawa (Bawa Biotech LLC; Rensselaer Polytechnic Institute), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd.; University of Basel, Switzerland), Melanie Brickman Stynes (The New York Academy of Sciences), and Melinda Miller (The New York Academy of Sciences)
    Keynote Speaker: Sally Tinkle (Science and Technology Policy Institute, IDA)

    This eBriefing explores regulatory challenges in the nascent field of nanomedicines.

    eBriefing

    The 8th Gotham-Metro Condensed Matter Meeting: Tapping NYC's Science and Engineering Talent

    Keynote Speakers: KC Huang (Stanford University) and Amir Yacoby (Harvard University)
    Panel Moderator: Seth Pinsky (NYC Economic Development Corporation)

    This eBriefing documents the 8th condensed matter physics conference featuring keynote talks in hard matter and soft matter as well as a special panel discussion, "Generation Tech: Tapping NYC's Science & Engineering Talent," featuring representatives of the new engineering and applied science institutions that are being created in the city.

    eBriefing

    Black Holes and Astrobiology

    Speaker: Caleb Scharf (Columbia University)

    This eBriefing documents a presentation by Caleb Scharf, director of astrobiology at Columbia University, who described the latest science on black holes and gave an update on the search for life on other planets.

  • Podcasts

    Podcast
    January 1, 2010

    The Science of Sushi

    Danish biophysicist Ole Mouritsen also happens to be an expert on, and lover of sushi. This week, we talk to him about his new book, Sushi: Food for the Eye, the Body, and the Soul.

    Download (9 MB, 00:14:52)
    Podcast
    December 18, 2009

    No Small Matter

    We sit down with science photographer Felice Frankel and nanotechnology pioneer and Harvard chemist George Whitesides to hear about their new book on nanoscience, No Small Matter.

    Download (11 MB, 00:18:04)
  • Webinar Archives

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.